共 50 条
- [21] Stable Pulmonary Function after Myeloimmunosupressive Conditioning (MIC) and Familial Haploidentical (FHI) Transplantation Utilizing CD34+Enrichment and PBMC (CD3) Add Back in Children and Young Adults with High Risk (HR) Sickle Cell Disease (SCD) [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S222 - S222
- [22] Assessment of Safety and Efficacy of PBSC Mobilization with G-CSF and CD34+Enrichment and Pbmnc (CD3+) Addback in Familial Haploidentical (FHI) Adult Donors with Sickle Cell Disease Trait (SCDT) Prior to Allogeneic HSCT of High-Risk SCD Patients [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
- [23] Assessment of Safety and Efficacy of PBSC Mobilization with G-CSF and CD34+Enrichment and Pbmnc (CD3+) Addback in Familial Haploidentical (FHI) Adult Donors with Sickle Cell Disease Trait (SCDT) Prior to Allogeneic HSCT of High-Risk SCD Patients [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S162 - S163
- [24] Determining the Safety and Efficacy of Prophylactic Defibrotide Administration in Children, Adolescents, and Young Adults with Sickle Cell Disease Following Myeloimmunoablative Conditioning (MAC) and Haploidentical Stem Cell Transplantation Utilizing CD34+Selection and T-Cell (CD3) Addback (IND127812) [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S212 - S213
- [25] DETERMINING THE SAFETY AND EFFICACY OF PROPHYLACTIC DEFIBROTIDE ADMINISTRATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH SICKLE CELL DISEASE FOLLOWING MYELOIMMUNOABLATIVE CONDITIONING (MAC) AND HAPLOIDENTICAL STEM CELL TRANSPLANTATION UTILIZING CD34+SELECTION AND T-CELL (CD3) ADDBACK (IND127812) [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S228 - S228
- [26] Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation Utilizing CD34 Enrichment and T Cell Addbacic in Children, Adolescents & Adults with High-Risk Sickle Cell Disease. Rapid Engraftment, Low Incidence of Agvhd, and Sustained Donor Chimerism [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S367 - S368
- [27] Neurocognitive & Neurological Outcomes in Children, Adolescents & Young Adults with High-Risk SCD Who Have Undergone Familial Haploidentical (FHI) Allosct Utilizing CD34 Enrichment and T Cell Addback Following Myeloimmunoablative Conditioning (MAC) [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S192 - S193
- [30] NEUROCOGNITIVE OUTCOMES IN CHILDREN, ADOLESCENTS & YOUNG ADULTS WITH HIGH-RISK SICKLE CELL DISEASE (SCD) FOLLOWING FAMILIAL HAPLOIDENTICAL (FHI) STEM CELL TRANSPLANTATION: A PROSPECTIVE STUDY FROM PRE HSCT PERIOD TO 2 YEARS POST HSCT (IND 14359) [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S223 - S224